Increased serum C‐reactive protein and decreased urinary aquaporin 2 levels are predictive of the efficacy of tolvaptan in patients with liver cirrhosis
暂无分享,去创建一个
N. Sakamoto | T. Sho | K. Morikawa | Koji Ogawa | N. Kawagishi | G. Suda | M. Ohara | M. Nakai | N. Kawagishi | J. Ito | M. Umemura | T. Izumi | Rei Takeda | Naoya Sakamoto | Kenichi Morikawa | Masato Nakai | Takaaki Izumi | Masatsugu Ohara